KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $43.6 billion.

  • Bristol Myers Squibb's Treasury Shares fell 20.38% to $43.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 billion, marking a year-over-year decrease of 20.38%. This contributed to the annual value of $43.7 billion for FY2024, which is 25.36% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Treasury Shares of $887.0 million as of Q3 2025, which was down 89.39% from $888.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Treasury Shares ranged from a high of $902.0 million in Q4 2023 and a low of $7.0 million during Q3 2021
  • Its 5-year average for Treasury Shares is $721.0 million, with a median of $834.0 million in 2023.
  • In the last 5 years, Bristol Myers Squibb's Treasury Shares skyrocketed by 2936.87% in 2022 and then decreased by 25.36% in 2024.
  • Bristol Myers Squibb's Treasury Shares (Quarter) stood at $31.3 billion in 2021, then increased by 23.54% to $38.6 billion in 2022, then increased by 13.33% to $43.8 billion in 2023, then dropped by 0.25% to $43.7 billion in 2024, then dropped by 0.16% to $43.6 billion in 2025.
  • Its Treasury Shares was $43.6 billion in Q3 2025, compared to $43.6 billion in Q2 2025 and $43.6 billion in Q1 2025.